OraSure Technologies Gross Margin 2010-2024 | OSUR
Current and historical gross margin for OraSure Technologies (OSUR) over the last 10 years. The current gross profit margin for OraSure Technologies as of September 30, 2024 is %.
| OraSure Technologies Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $0.22B | $0.10B | 45.09% |
| 2024-06-30 | $0.27B | $0.13B | 46.89% |
| 2024-03-31 | $0.30B | $0.13B | 42.43% |
| 2023-12-31 | $0.41B | $0.17B | 42.22% |
| 2023-09-30 | $0.45B | $0.19B | 41.15% |
| 2023-06-30 | $0.48B | $0.19B | 39.46% |
| 2023-03-31 | $0.47B | $0.19B | 40.30% |
| 2022-12-31 | $0.39B | $0.15B | 38.50% |
| 2022-09-30 | $0.33B | $0.13B | 38.41% |
| 2022-06-30 | $0.27B | $0.10B | 37.59% |
| 2022-03-31 | $0.24B | $0.10B | 42.21% |
| 2021-12-31 | $0.24B | $0.12B | 49.79% |
| 2021-09-30 | $0.23B | $0.13B | 54.70% |
| 2021-06-30 | $0.23B | $0.14B | 60.09% |
| 2021-03-31 | $0.20B | $0.12B | 61.81% |
| 2020-12-31 | $0.17B | $0.10B | 58.72% |
| 2020-09-30 | $0.16B | $0.09B | 58.49% |
| 2020-06-30 | $0.15B | $0.09B | 57.82% |
| 2020-03-31 | $0.16B | $0.09B | 59.24% |
| 2019-12-31 | $0.16B | $0.10B | 61.29% |
| 2019-09-30 | $0.16B | $0.10B | 64.52% |
| 2019-06-30 | $0.17B | $0.11B | 64.85% |
| 2019-03-31 | $0.17B | $0.11B | 63.53% |
| 2018-12-31 | $0.18B | $0.11B | 62.64% |
| 2018-09-30 | $0.18B | $0.11B | 58.70% |
| 2018-06-30 | $0.18B | $0.10B | 57.78% |
| 2018-03-31 | $0.18B | $0.10B | 58.52% |
| 2017-12-31 | $0.17B | $0.10B | 59.28% |
| 2017-09-30 | $0.15B | $0.09B | 62.67% |
| 2017-06-30 | $0.14B | $0.09B | 65.71% |
| 2017-03-31 | $0.13B | $0.09B | 67.18% |
| 2016-12-31 | $0.13B | $0.09B | 69.29% |
| 2016-09-30 | $0.12B | $0.09B | 69.35% |
| 2016-06-30 | $0.12B | $0.08B | 68.85% |
| 2016-03-31 | $0.12B | $0.08B | 69.42% |
| 2015-12-31 | $0.12B | $0.08B | 68.07% |
| 2015-09-30 | $0.12B | $0.08B | 66.38% |
| 2015-06-30 | $0.11B | $0.08B | 65.79% |
| 2015-03-31 | $0.11B | $0.07B | 63.64% |
| 2014-12-31 | $0.11B | $0.07B | 62.62% |
| 2014-09-30 | $0.11B | $0.07B | 61.68% |
| 2014-06-30 | $0.10B | $0.06B | 59.62% |
| 2014-03-31 | $0.10B | $0.06B | 58.82% |
| 2013-12-31 | $0.10B | $0.06B | 58.59% |
| 2013-09-30 | $0.09B | $0.05B | 58.70% |
| 2013-06-30 | $0.09B | $0.05B | 59.55% |
| 2013-03-31 | $0.09B | $0.05B | 61.36% |
| 2012-12-31 | $0.09B | $0.06B | 63.64% |
| 2012-09-30 | $0.09B | $0.06B | 64.44% |
| 2012-06-30 | $0.09B | $0.06B | 64.44% |
| 2012-03-31 | $0.09B | $0.06B | 63.95% |
| 2011-12-31 | $0.08B | $0.05B | 63.41% |
| 2011-09-30 | $0.08B | $0.05B | 63.64% |
| 2011-06-30 | $0.07B | $0.05B | 63.51% |
| 2011-03-31 | $0.07B | $0.05B | 63.51% |
| 2010-12-31 | $0.08B | $0.05B | 62.67% |
| 2010-09-30 | $0.08B | $0.05B | 61.04% |
| 2010-06-30 | $0.08B | $0.05B | 61.25% |
| 2010-03-31 | $0.08B | $0.05B | 60.26% |
| 2009-12-31 | $0.08B | $0.05B | 61.04% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.289B | $0.405B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.977B | 28.52 |
| Boston Scientific (BSX) | United States | $155.488B | 41.98 |
| Stryker (SYK) | United States | $147.446B | 31.70 |
| EssilorLuxottica (ESLOY) | France | $140.780B | 0.00 |
| Medtronic (MDT) | Ireland | $112.764B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.084B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.818B | 29.12 |
| GE HealthCare Technologies (GEHC) | United States | $42.113B | 20.51 |
| Agilent Technologies (A) | United States | $39.025B | 25.86 |
| ResMed (RMD) | United States | $34.189B | 26.33 |
| Terumo (TRUMY) | Japan | $26.310B | 37.41 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.630B | 12.95 |
| Insulet (PODD) | United States | $20.222B | 86.57 |
| Baxter (BAX) | United States | $17.074B | 12.34 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.245B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.513B | 35.65 |
| Bio-Rad Laboratories (BIO) | United States | $8.001B | 27.70 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 13.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.200B | 20.05 |
| ICU Medical (ICUI) | United States | $3.995B | 38.03 |
| Envista Holdings (NVST) | United States | $3.693B | 29.38 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.188B | 15.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.921B | 19.69 |
| QuidelOrtho (QDEL) | United States | $2.760B | 23.18 |
| LeMaitre Vascular (LMAT) | United States | $2.269B | 55.15 |
| Neogen (NEOG) | United States | $2.178B | 25.10 |
| AtriCure (ATRC) | United States | $1.914B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.90 |
| InMode (INMD) | Israel | $1.320B | 11.03 |
| BioLife Solutions (BLFS) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.180B | 8.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.997B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.938B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.930B | 14.27 |
| Evolus (EOLS) | United States | $0.926B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.689B | 0.00 |
| Valneva SE (VALN) | France | $0.643B | 0.00 |
| Omeros (OMER) | United States | $0.557B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.494B | 3.86 |
| Surmodics (SRDX) | United States | $0.492B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.321B | 58.60 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.52 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| Biote (BTMD) | United States | $0.260B | 5.69 |
| Canopy Growth (CGC) | Canada | $0.250B | 0.00 |
| Zynex (ZYXI) | United States | $0.236B | 49.40 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| Brainsway (BWAY) | Israel | $0.212B | 112.80 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.39 |
| MacroGenics (MGNX) | United States | $0.181B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 12.79 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| InterCure (INCR) | Israel | $0.075B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Exagen (XGN) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.058B | 30.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| MariMed (MRMD) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.22 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| INLIF (INLF) | $0.040B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |